Healthcare Market Research Reports and Trends

According to a new market research report “ Refurbished Medical Equipment Market  (X-Ray, Ultrasound, MRI, CT Scanner, Nuclear Imaging Systems, Heart-Lung Machine, Surgical, CO2 Monitor, Patient Monitor, Pulse Oximeter, AED Defibrillator, Cath Labs, Neonatal, Endoscopy) – Global Forecast to 2021″ published by MarketsandMarkets, the global market is expected to reach USD 11.91 Billion by 2021, at CAGR of 12.7% from 2016 to 2021. This report studies the global Refurbished Medical Equipment Market over the forecast period of 2016 to 2021. The report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Product On the basis of product, the global Refurbished Medical Equipment Market is divided into 11 major segments, namely, operating room equipment & surgical equipment, patient monitors, defibrillators, neurology equipment, medical imaging equipment, cardiovascul...

According to a new market research report " Biological Safety Cabinet Market  by Type (Class I, Class II (Type A, Type B), Class III), End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories, Academic & Research Institution) - Global Forecast to 2022", published by MarketsandMarkets™, the market is projected to reach USD 205.9 Million by 2022 from USD 144.3 Million in 2017, at a CAGR of 7.4%. Growth in the Biological Safety Cabinets Market is primarily driven by factors such as favorable regulations driving the use of biological safety cabinets in the healthcare industry, increased risk of pandemics and communicable diseases, increasing number of R&D activities in biotechnological and pharmaceutical companies, and rapid growth in the number of biologics. Request for Sample Pages -  https://www.marketsandmarkets.com/requestsampleNew.asp?id=60228904 The Class II biological safety cabinets segment accounted for the largest s...

Parkinson’s disease treatment is used to treat the symptoms of Parkinson’s disease, generally, medication is the first line treatment for this disease. Rising geriatric population and government funding for research on Parkinson’s disease are the driving factors for this market. The  global Parkinson’s disease treatment market  is expected to reach $5.69 billion by 2022 from $4.24 billion in 2017, at a  CAGR  of 6.1%. Segments The Parkinson’s disease treatment market is segmented on the basis of drug class, distribution channel, patient care setting, and region. On the basis of drug class, the market is segmented into carbidopa/levodopa, dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs. The carbidopa/levodopa segment is expected to account for the largest share of the market in 2017. The growth in this segment is primarily attributed to the potency of the drug. By distribution channel, the market is segmented...

Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. The  global vitamin D therapy market  is projected to reach $3.3 billion by 2024 from $1.9 billion in 2019, at a  CAGR  of 11.6%. Oral route of administration expected to fuel the growth of the vitamin D therapy market over the forecast period By route of administration, the market is segmented into oral and parenteral routes of administration. The oral route of administration is expected to register the largest share and highest CAGR during the forecast period. This can be attributed to the ease of administration, better pharmacokinetic and pharmacodynamic activity, reduced chance of toxicity, increased patient compliance, and higher preference for the oral route. Increasing use of vitamin D in osteoporosis to dri...

Increasing R&D spending in the pharmaceutical and biopharmaceutical industries and increasing purity requirements among end users of track etched membranes. However, the high cost of production and the limited supply of track etched Membranes are major factors that are expected to restrain the growth of this market. The  Global Track etched Membrane Market  is expected to reach $813.1 million by 2023 from $476.0 million in 2018, at a  CAGR  of 11.3% from 2018 to 2023. Applications The track etched membrane market is segmented into cell biology, microbiology, analytical testing, and other applications. The cell biology segment is estimated to hold the largest share of the track etched membrane market in 2018. The growing adoption of cell culture-based vaccines, increasing demand for monoclonal antibodies, rising funding for cell-based research, and the launch of advanced cell culture products are factors expected to drive the cell biology seg...

Rising prevalence of chronic diseases, favorable reimbursement scenario and government support, and the increasing number of regulatory approvals resulting in the increased adoption among patients. The  global  injection pen market  is expected to reach $41.38 Billion by 2022 from $30.97 Billion in 2017, at a  CAGR  of 6.0%. Segments The market is segmented on the basis of type, therapy, end user, and region. Based on type, the market is segmented into disposable and reusable injection pens. The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the benefits disposable pens offer, such as portability, ease of use, and low possibility of infection. Based on therapy, the global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies (such as multiple sclerosis, obesity, cardiovascular diseas...

The increase in the prevalence of lung cancer & chronic respiratory disorders globally, combined with the increasing preference for minimally invasive procedures are some of the factors contributing to the growth of this market. However, the associated complication of using these stents and an increase in the availability of alternative treatments might hamper the growth of the airway/lung stents market. The  lung stent market  is projected to reach $120 million by 2024 from $87 million in 2019, at a CAGR of 6.7%. Market Dynamics + Drivers  + Rising Prevalence of Lung Cancer and Respiratory Diseases + Increasing Preference for Minimally Invasive Procedures + Continuous Growth in the Healthcare Industry + Increasing Life Expectancy + Rising Healthcare Expenditure + Growing Geriatric Population Request for Free Sample Pages –  https://www.marketsandmarkets.com/requestsampleNew.asp?id=32315890 The market is segmented based on the type, material, produc...

Major factors driving the growth of this market include growing prevalence of cardiac conditions and the subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide. However, adoption of alternative surgical methods and lack of Medicare payments may restrain the growth of this market. The  overall cardiac surgery instruments market  is expected to reach $1.63 Billion by 2022 from $1.16 Billion in 2017 at a CAGR of 7.1%.  North America dominated the global cardiac surgery instruments market in 2017, with the U.S. accounting for a major share of this regional market. Factors such as high incidence of cardiac diseases, rising awareness programs and increased funding for research projects are likely to drive the growth of the North American market. Followed by North America, Europe dominated the global market in 2017. The European market is mainly driven by increasing ...

Factors contributing to the growth of this market include the benefits of cold plasma, such as its environment-friendliness; innovations in textile production; growing food safety concerns; innovations in cold plasma technology ; and the increasing use of cold plasma in meat and poultry packaging decontamination. The surface treatment segment accounted for the largest share of the cold plasma market for the polymer and plastic industry. This market segment is majorly driven by the advantages of cold plasma surface treatment, such as increased durability, better hydrophobic properties, higher packing density, better film quality, enhanced coating surface smoothness, and lower cost. Download Sample Pages The benefits of cold plasma technology in wound healing applications—faster healing and better results, sterilization efficiency, & cost-effectiveness as compared to conventional methods Some Key Players Nordson Corporation (U.S.), Bovie Medical Corporation (US), ADT...

Growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options. However, the high cost and low success rate of the IVF treatment and restrictive regulation and ethical concerns are expected to restrict the growth of market to a certain extent. Imaging systems, sperm separation systems, cabinets (workstations), ovum aspiration pumps, incubators, micromanipulator systems, cryosystems, gas analyzers, laser analyzers, anti-vibration tables, accessories, and witness systems. However, sperm separation systems are expected to witness the highest growth, due to factors such as the rising use of donated sperm in IVF procedures. Sample Pages The global IVF market has been segmented into fertility clinics and surgical centers, hospitals and research laboratories, and cryobanks. The fertility clinics and surgical centers...